The market for clinical trials has started capturing new geographies owing to the growing awareness of healthcare, bullish demand for therapy methods’ improvements and ongoing technological advancements in the medical equipment industry, enhancing incidence of chronic diseases and the population ageing. Currently, companies engaged in the clinical trials industry tend to move from the mature markets (North America, Oceania and Western Europe) to the emerging ones (Asia, Latin America, Eastern Europe), since the latter ones offer such advantages as a great number of potential patients, lower labor costs and working expenditures and other economic benefits. The US, Canada, Germany and Poland represent the largest country markets for clinical trials. Parexel, Quintles, Chiltern, PPD, Kendle and Omnicare are amid the giants of the worldwide clinical trials market.
Extensive analyses of the clinical trials market are provided in the research reports found under this catalogue. The researches include significant data on the market size, structure and trends, indicate major forces impacting the market. The reports offer detailed evaluation of the market competition and profile key market players. In addition, the future outlooks for the clinical trials market are disposed in the research reports.
Publications found:
114
Sort by:
Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026
US$ 4,450.00
Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by t...
May 2021
113 pages
Ascites Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Ascites Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Ascites Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Ascites Clinical tri...
February 2021
137 pages
Germ Cell Tumors - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Germ Cell Tumors - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Germ Cell Tumors - Global Clinical Trials Review, H1, 2021' provides an overview of Germ Cell Tumors C...
February 2021
247 pages
Alopecia Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Alopecia Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Alopecia Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Alopecia Clinical...
January 2021
318 pages
Fatigue Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Fatigue Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Fatigue Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Fatigue Clinical tri...
January 2021
392 pages
Fabry Disease - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Fabry Disease - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Fabry Disease - Global Clinical Trials Review, H1, 2021' provides an overview of Fabry Disease Clinical t...
January 2021
115 pages
Sezary Syndrome - Global Clinical Trials Review, H1, 2021
US$ 2,500.00
Sezary Syndrome - Global Clinical Trials Review, H1, 2021 GlobalData's clinical trial report, “Sezary Syndrome - Global Clinical Trials Review, H1, 2021' provides an overview of Sezary Syndrome Clin...
January 2021
165 pages
Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End, and Geography - Global Forecast to 2027
US$ 4,175.00
Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services, and others), Therapeutic Area, End,...
January 2021
240 pages
Coronavirus Disease 2019 (COVID-19) Impact on Novavax Inc.
US$ 495.00
Coronavirus Disease 2019 (COVID-19) Impact on Novavax Inc. SUMMARY Novavax is a late-stage clinical biotechnology company with a recombinant subunit innovative vaccine platform and an adjuvant platf...
December 2020
29 pages
Active Pharmaceutical Ingredients: Global Markets
US$ 5,500.00
... (Active Pharmaceutical Ingredients: Global Markets to 2022) covers an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing ...
December 2020
148 pages
Burns Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Burns Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Burns Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Burns Clinical t...
December 2020
291 pages
Delirium Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Delirium Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Delirium Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Delirium C...
December 2020
296 pages
Tetanus Disease - Global Clinical Trials Review, H2, 2020
US$ 2,500.00
Tetanus Disease - Global Clinical Trials Review, H2, 2020 SUMMARY GlobalData's clinical trial report, “Tetanus Disease - Global Clinical Trials Review, H2, 2020' provides an overview of Tetanus Clin...
December 2020
276 pages
